Lisa K. Peterson, PhD, D(ABMLI)

Associate Professor, University of Utah School of Medicine

Specialties

• Immunodeficiency
• Autoimmunity
• Autoimmune neurology

Education

• Doctorate Degree—Experimental Pathology, University of Utah
• Fellowship—Immunology, National Jewish Health and University of Colorado Health Sciences Center
• Fellowship—Clinical Immunology, University of Utah and ARUP Laboratories

Certification/Affiliations

• American Board of Medical Laboratory Immunology
• Association of Medical Laboratory Immunologists
• Clinical Immunology Society
• American Academy of Neurology
• American Association for Clinical Chemistry
• American Society for Microbiology

Research Interests

• Immunodeficiency
• Autoimmunity
• Autoimmune neurology

Awards

• Doctorate Award, Association of Medical Laboratory Immunologists, 2016
• Young Investigator Award, Colorado Immunology Conference, American Association of Immunologists, 2013

Recent Publications

• Hoshina Y, Liu S, Wright MA, et al. Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. J Neuroimmunol. 2025;407:578709.
• Hoshina Y, Smith TL, Mstat AD, et al. An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote. J Neuroimmunol. 2025;405:578651.
• Peterson LK, Nandakumar V, Valentine JF, et al. The utility of the immunoglobulin A flag used in celiac disease serology testing on a particle-based multianalyte technology platform. Clin Chem. 2025;71(7):818-820.
• Lázár-Molnár E, Peterson LK. Clinical utility of the lymphocyte proliferation assay, an in vitro functional readout of the adaptive immune response. J Immunol Methods. 2025;537:113819.
• Moyle KA, Branch DW, Peterson LK, et al. Association between novel antiphospholipid antibodies and adverse pregnancy outcomes. Obstet Gynecol. 2025;145(1):55-64.
• Hoshina Y, Abbatemarco JR, Rodenbeck SJ, e al. Matched oligoclonal bands: diagnostic utility and clinical characteristics. Ann Clin Transl Neurol. 2024;11(11):2846-2854.
• Martins TB, Hill HR, Peterson LK. Evaluating patient immunocompetence through antibody response to pneumococcal polysaccharide vaccine using a newly developed 23 serotype multiplexed assay. Clin Immunol. 2024;265:110295.
• Martins TB, Hill HR, Peterson LK. Specimen type validation and establishment of normal cytokine reference intervals in cerebrospinal fluid. J Immunol Methods. 2024;529:113681.
• Luong K, Lozier BK, Novis CL, e al. Comparison of three methods for the detection of antibodies against muscle-specific kinase. J Immunol Methods. 2024;526:113627.
• Smith TL, Haven TR, Zuromski LM, et al. High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Front Neurol. 2023;14:1192644.
• Tebo AE, Peterson LK, Snyder MR, et al. Clinical significance of anti-U1 ribonucleoprotein antibody is analyte dependent: implications for laboratory reporting, interpretation, and interassay correlations. Arch Pathol Lab Med. 2023;147(12):1461-1465.
• Peterson LK. Application of vaccine response in the evaluation of patients with suspected B-cell immunodeficiency: assessment of responses and challenges with interpretation. J Immunol Methods. 2022;510:113350.